iDose TR Administration in an Office-Based Surgery Setting
for Open Angle Glaucoma (OAG)
1 location in Austin
Sponsor: Glaukos Corporation
Sex: All·Age: 18+
Code: NCT07816692·Recruiting·Listed Sep 14, 2026
Paid Clinical Trials in Austin, TX
As of September 2026, 679 paid clinical trials are recruiting in Austin, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Austin offers studies at sites including Dell Children's Medical Center of Central Texas for conditions such as Obesity, Heart Failure, Overweight, Endometrial Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Austin
Trials by drug in Austin
Filter results
Filter results
Newly added in Austin
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
for Type 2 Diabetes
Sites in Austin, San Antonio +107 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 45+
Code: NCT07797335·Phase 3·Recruiting·Listed Sep 1, 2026
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for Smoking Cessation
Sites in Austin, Fort Worth +14 more locations
Sponsor: Axsome Therapeutics, Inc.
Sex: All·Age: 18 - 65
Code: NCT07766655·Phase 3·Recruiting·Listed Aug 14, 2026
Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
for Non-Muscle Invasive Bladder Cancer
1 location in Austin
Sponsor: Natera, Inc.
Sex: All·Age: 18+
Code: NCT07763197·Recruiting·Listed Aug 13, 2026
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
for Multiple Sclerosis
1 location in Austin
Sponsor: University of Texas at Austin
Sex: All·Age: 18 - 80
Code: NCT07759115·Recruiting·Listed Aug 12, 2026
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
for Attention-deficit/Hyperactivity Disorder
Sites in Austin, Bellaire +14 more locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All·Age: 18 - 65
Code: NCT07759154·Phase 3·Recruiting·Listed Aug 12, 2026
610 clinical trials
Get a weekly email when new trials open in Austin, TX.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
Drug: Elismetrep
Sites in Austin, Lampasas +111 more locations
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 2026
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
for Diabetes Mellitus, Type 2
Sites in Austin, Lampasas +23 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18 - 75
Code: NCT07668388·Phase 2·Recruiting·Listed Jun 2026
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
for Neovascular Age-related Macular Degeneration
Drug: Aflibercept
Sites in Austin, Schertz +52 more locations
Sponsor: Amgen
Sex: All·Age: 50+
Code: NCT07614776·Phase 3·Recruiting·Listed May 2026
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
for Obesity
Drug: NNC0487-0111
Sites in Austin, Round Rock +204 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07567001·Phase 3·Recruiting·Listed May 2026
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for Overweight
Drug: Eloralintide
Sites in Austin, San Antonio +38 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07589608·Phase 2·Recruiting·Listed May 2026
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
Drug: Donanemab
Sites in Austin, Houston +50 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
Sites in Austin +29 more locations
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for Major Depressive Episode (MDE)
Sites in Austin, Plano +23 more locations
Sponsor: Tonix Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07621237·Phase 2·Recruiting·Listed Jun 2026
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
for Diabetic Macular Edema
Sites in Austin, San Antonio +26 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07553429·Phase 1, Phase 2·Recruiting·Listed Apr 2026
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
for Urothelial Cancer
Drug: PF-08634404
Sites in Austin, Waco +131 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
for Macular Degeneration
Sites in Austin, The Woodlands +62 more locations
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07440225·Phase 2, Phase 3·Recruiting·Listed Feb 2026
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for Lichen Planopilaris
Sites in Austin, Cedar Park +45 more locations
Sponsor: Priovant Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07532603·Phase 2, Phase 3·Recruiting·Listed Apr 2026
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
for MASH - Metabolic Dysfunction-Associated Steatohepatitis
Sites in Austin, Georgetown +29 more locations
Sponsor: Rivus Pharmaceuticals, Inc.
Sex: All·Age: 30+
Code: NCT07491458·Phase 2·Recruiting·Listed Mar 2026
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for Non-small Cell Lung Cancer (NSCLC)
Drug: Durvalumab
Sites in Austin, San Antonio +35 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07361497·Phase 3·Recruiting·Listed Jan 2026
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for Post Traumatic Stress Disorder
Drug: TSND-201
Sites in Austin, Houston +30 more locations
Sponsor: Transcend Therapeutics
Sex: All·Age: 18+
Code: NCT07456696·Phase 3·Recruiting·Listed Mar 2026
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
for Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Ixo-vec
Sites in Austin, San Marcos +77 more locations
Sponsor: Adverum Biotechnologies, Inc.
Sex: All·Age: 50+
Code: NCT07482176·Phase 3·Recruiting·Listed Mar 2026
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for Type 2 Diabetes
Sites in Austin, Round Rock +58 more locations
Sponsor: Sparrow Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07296484·Phase 2·Recruiting·Listed Dec 2025
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for Metabolic Dysfunction-associated Steatohepatitis
Sites in Austin, Georgetown +61 more locations
Sponsor: Eccogene
Sex: All·Age: 18 - 75
Code: NCT07288138·Phase 2·Recruiting·Listed Dec 2025
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for Schizophrenia
Drug: KarXT
Sites in Austin, San Antonio +53 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07379827·Recruiting·Listed Feb 2026
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for Advanced Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Austin, Waco +204 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for Overweight
Drug: Eloralintide
Sites in Austin, San Antonio +58 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for Ventricular Arrythmia
Sites in Austin +26 more locations
Sponsor: AtaCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT07324031·Recruiting·Listed Jan 2026
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in Austin, Temple +73 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for Non-small Cell Carcinoma
Sites in Austin, Round Rock +221 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
for Carcinoma, Renal Cell
Drug: PF-08634404
Sites in Austin, Waco +107 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
Sites in Austin, San Antonio +68 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Austin, Sugar Land +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for Untreated, Unresectable, or Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in Austin, San Antonio +42 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221357·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sites in Austin, San Antonio +140 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Austin, San Antonio +32 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
for Diabetic Peripheral Neuropathic Pain
Drug: LY4065967
Sites in Austin, Fort Worth +34 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07285018·Phase 2·Recruiting·Listed Dec 2025
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for Diabetes Mellitus, Type 2
Drug: Empagliflozin
Sites in Austin, San Marcos +200 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07064473·Phase 3·Recruiting·Listed Jul 2025
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
Drug: Muvalaplin
Sites in Austin, Lampasas +155 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Austin, The Woodlands +62 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Austin, San Antonio +37 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Austin, San Marcos +192 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in Austin, The Woodlands +85 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
for Atherosclerotic Cardiovascular Disease
Sites in Austin, San Antonio +135 more locations
Sponsor: Amgen
Sex: All·Age: 45 - 99
Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for Major Depressive Disorder
Drug: Icalcaprant
Sites in Austin, Bellaire +31 more locations
Sponsor: AbbVie
Sex: All·Age: 18 - 65
Code: NCT07276997·Phase 2·Recruiting·Listed Dec 2025
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
for Metabolic Dysfunction Associated Steatohepatitis (MASH)
Drug: Survodutide
Sites in Austin, Georgetown +161 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024
Top Research Study Locations in Austin
Researchers run research studies in Austin, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dell Children's Medical Center of Central Texas | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 33 |
| University of Texas at Austin | Stroke, Alcohol Drinking, Alzheimer Disease | 23 |
| The University of Texas at Austin | Attention Deficit Hyperactivity Disorder, Healthy, Multiple Sclerosis | 22 |
| FutureSearch Trials of Neurology | Chronic Pain, Migraine, Obesity | 13 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Asthma | 12 |
| Austin Clinical Trial Partners | Major Depressive Disorder, Depression, Generalized Anxiety Disorder | 11 |
| Dell Children's Medical Center | AAOCA, Acute Treatment of Migraine, Adolescent Idiopathic Scoliosis | 11 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Advanced or Metastatic Renal Cell Carcinoma | 10 |
| Austin Heart | Heart Failure, Obesity, Heart Failure With Preserved Ejection Fraction | 10 |
| Texas Cardiac Arrhythmia Research Foundation | Atrial Fibrillation, Heart Failure, Atrial Enlargement | 10 |
| Urology Austin | Prostate Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Bladder (Urothelial, Transitional Cell) Cancer | 10 |
| NEXT Austin | Advanced Solid Tumors, Endometrial Cancer, Advanced Solid Tumor | 9 |
| National Neuromuscular Research Institute | Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis | 8 |
| Texas Oncology - Central/South Texas | Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer | 7 |
| Austin Retina Associates | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD) | 7 |
| Ascension Texas Cardiovascular | Aortic Valve Stenosis, Atrial Fibrillation, Cardiovascular Diseases | 7 |
| IMA Clinical Research Austin | Overweight, Obesity, Liver Fibrosis | 7 |
| St. David's South Austin Medical Center | AML, MDS, Multiple Myeloma | 7 |
| Dell Seton Medical Center at The University of Texas | Acute Pain, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 6 |
| NEXT Oncology | Locally Advanced (Unresectable) or Metastatic Solid Tumors, Ovarian Cancer, Solid Tumor | 6 |
| Texas Oncology | CRC (Colorectal Cancer), HER2-low Hormone Receptor Positive Breast Cancer, Melanoma (Skin Cancer) | 6 |
| University of Texas | Logopenic Progressive Aphasia, Logopenic Progressive Aphasia (LPA), Logopenic Variant Primary Progressive Aphasia | 6 |
| Austin Neuromuscular Center | Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) | 5 |
| Austin Clinical Research, LLC | Diabetic Macular Edema, Geographic Atrophy, Macular Edema | 5 |
| Dell Children's Blood and Cancer Center | Neuroblastoma, Medulloblastoma, Pediatric Cancer | 5 |
Active & Upcoming Studies in Austin (2026)
Recruiting trials in Austin grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (171 active studies)
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Neurology & pain (54 active studies)
- Weighted Blankets for Pain and Anxiety in Adult Trauma Patients · University of Texas at Austin
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Mental health & behavior (50 active studies)
- Self-Compassion, Health, and Empowerment · Yang Li
- Mindfulness-based Relapse Prevention for Peer Workers · University of Texas at Austin
Diabetes & metabolic (49 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) · Phase 3 · Eli Lilly and Company
Cardiovascular (47 active studies)
Eye & vision (23 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Pediatric (12 active studies)
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
- Pressure Targeting During High Flow Therapy in Premature Infants · Phase 2 · University of Texas at Austin
Vaccines (4 active studies)
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older · Phase 1, Phase 2 · Sanofi
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
HIV / STI (4 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Common conditions studied in Austin
- Obesity (20 active studies)
- Heart Failure (17 active studies)
- Overweight (16 active studies)
- Endometrial Cancer (13 active studies)
- Breast Cancer (12 active studies)
- Schizophrenia (12 active studies)
Leading research sponsors in Austin
- University of Texas at Austin
- AbbVie
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Austin?
There are approximately 679 recruiting clinical trials in Austin, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Austin pay participants?
Most recruiting trials in Austin compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Austin?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Austin?
The most common conditions under active study in Austin include Obesity (20), Heart Failure (17), Overweight (16), Endometrial Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Austin?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Austin on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Austin?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Austin?
Recruiting research sites in Austin include Dell Children's Medical Center of Central Texas, University of Texas at Austin, The University of Texas at Austin, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Austin right now?
The largest active categories in Austin are Cancer & tumors (171), Neurology & pain (54), Mental health & behavior (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Texas
Houston, TX(3,044)Dallas, TX(1,565)San Antonio, TX(982)Fort Worth, TX(329)El Paso, TX(188)Plano, TX(168)Tyler, TX(157)Sugar Land, TX(127)Irving, TX(113)The Woodlands, TX(109)Lubbock, TX(106)Bellaire, TX(101)Amarillo, TX(83)Richardson, TX(82)Galveston, TX(81)McAllen, TX(72)McKinney, TX(69)Temple, TX(69)Corpus Christi, TX(66)DeSoto, TX(65)Webster, TX(64)Mesquite, TX(61)Arlington, TX(60)Tomball, TX(53)Waco, TX(52)Abilene, TX(49)Beaumont, TX(48)Katy, TX(47)Round Rock, TX(47)Cypress, TX(45)Kingwood, TX(43)Edinburg, TX(40)Frisco, TX(40)Conroe, TX(39)Lewisville, TX(39)Baytown, TX(37)League City, TX(37)Denton, TX(35)Southlake, TX(33)Humble, TX(32)Denison, TX(31)Harlingen, TX(31)Mansfield, TX(31)Weslaco, TX(31)Wichita Falls, TX(31)Brownsville, TX(29)Shavano Park, TX(28)Georgetown, TX(27)Allen, TX(25)Longview, TX(24)Richmond, TX(24)Carrollton, TX(22)Sherman, TX(22)College Station, TX(21)Fort Sam Houston, TX(20)Flower Mound, TX(19)Garland, TX(19)Bedford, TX(18)Cedar Park, TX(18)Pasadena, TX(18)